https://orcid.org/0000-0003-0297-1209
FXIII-A increases FXIII-B levels in plasma, but FXIII-A does not induce de novo FXIII-B synthesis or release from hepatocytes.
The FXIII-A and FXIII-B subunits exhibit reciprocal stabilization in plasma.
Subjects:
Thrombosis and Hemostasis
Abstract
Transglutaminase factor XIII (FXIII) is essential for hemostasis, wound healing, and pregnancy maintenance. Plasma FXIII is composed of A and B subunit dimers synthesized in cells of hematopoietic origin and hepatocytes, respectively. The subunits associate tightly in circulation as FXIII-A2B2. FXIII-B2 stabilizes the (pro)active site-containing FXIII-A subunits. Interestingly, people with genetic FXIII-A deficiency have decreased FXIII-B2, and therapeutic infusion of recombinant FXIII-A2 (rFXIII-A2) increases FXIII-B2, suggesting FXIII-A regulates FXIII-B secretion, production, and/or clearance. We analyzed humans and mice with genetic FXIII-A deficiency and developed a mouse model of rFXIII-A2 infusion to define mechanisms mediating plasma FXIII-B levels. Like humans with FXIII-A deficiency, mice with genetic FXIII-A deficiency had reduced circulating FXIII-B2, and infusion of FXIII-A2 increased FXIII-B2. FXIII-A-deficient mice had normal hepatic function and did not store FXIII-B in liver, indicating FXIII-A does not mediate FXIII-B secretion. Transcriptional analysis and polysome profiling indicated similar F13b levels and ribosome occupancy in FXIII-A-sufficient and -deficient mice and in FXIII-A-deficient mice infused with rFXIII-A2, indicating FXIII-A does not induce de novo FXIII-B synthesis. Unexpectedly, pharmacokinetic/pharmacodynamic modeling of FXIII-B antigen after rFXIII-A2 infusion in humans and mice suggested FXIII-A2 slows FXIII-B2 loss from plasma. Accordingly, comparison of free FXIII-B2 vs FXIII-A2-complexed FXIII-B2 (FXIII-A2B2) infused into mice revealed faster clearance of free FXIII-B2. These data show FXIII-A2 prevents FXIII-B2 loss from circulation and establish the mechanism underlying FXIII-B2 behavior in FXIII-A deficiency and during rFXIII-A2 therapy. Our findings reveal a unique, reciprocal relationship between independently synthesized subunits that mediate an essential hemostatic protein in circulation. This trial was registered at www.ClinicalTrials.com as #NCT00978380.
Subjects:
Thrombosis and Hemostasis
References
1.
Schwartz
ML
, Pizzo
SV
, Hill
RL
, McKee
PA
. The subunit structures of human plasma and platelet factor XIII
. J Biol Chem
. 1971
;246
(18
):5851
-5854
.2.
Katona
É
, Pénzes
K
, Csapó
A
, et al. Interaction of factor XIII subunits
. Blood
. 2014
;123
(11
):1757
-1763
.3.
Akhter
MS
, Singh
S
, Yadegari
H
, Ivaskevicius
V
, Oldenburg
J
, Biswas
A
. Exploring the structural similarity yet functional distinction between coagulation factor XIII-B and complement factor H sushi domains
. J Thromb Thrombolysis
. 2019
;48
(1
):95
-102
.4.
Lorand
L
, Graham
RM
. Transglutaminases: crosslinking enzymes with pleiotropic functions
. Nat Rev Mol Cell Biol
. 2003
;4
(2
):140
-156
.5.
Muszbek
L
, Bereczky
Z
, Bagoly
Z
, Komáromi
I
, Katona
É
. Factor XIII: A coagulation factor with multiple plasmatic and cellular functions
. Physiol Rev
. 2011
;91
(3
):931
-972
.6.
Wölpl
A
, Lattke
H
, Board
PG
, et al. Coagulation factor XIII A and B subunits in bone marrow and liver transplantation
. Transplantation
. 1987
;43
(1
):151
-153
.7.
Beckers
CML
, Simpson
KR
, Griffin
KJ
, et al. Cre/lox studies identify resident macrophages as the major source of circulating coagulation factor XIII-A
. Arterioscler Thromb Vasc Biol
. 2017
;37
(8
):1494
-1502
.8.
Lonsdale
J
, Thomas
J
, Salvatore
M
, et al. The genotype-tissue expression (GTEx) project
. Nat Genet
. 2013
;45
(6
):580
-585
.9.
Yorifuji
H
, Anderson
K
, Lynch
GW
, Van de Water
L
, McDonagh
J
. B protein of factor XIII: differentiation between free B and complexed B
. Blood
. 1988
;72
(5
):1645
-1650
.10.
Fear
JD
, Miloszewski
KJ
, Losowsky
MS
. The half life of factor XIII in the management of inherited deficiency
. Thromb Haemost
. 1983
;49
(2
):102
-105
.11.
Lovejoy
AE
, Reynolds
TC
, Visich
JE
, et al. Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency
. Blood
. 2006
;108
(1
):57
-62
.12.
Inbal
A
, Oldenburg
J
, Carcao
M
, Rosholm
A
, Tehranchi
R
, Nugent
D
. Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency
. Blood
. 2012
;119
(22
):5111
-5117
.13.
Muszbek
L
, Katona
É
. Diagnosis and management of congenital and acquired FXIII deficiencies
. Semin Thromb Hemost
. 2016
;42
(4
):429
-439
.14.
Nugent
DJ
, Ashley
C
, García-Talavera
J
, Lo
LC
, Mehdi
AS
, Mangione
A
. Pharmacokinetics and safety of plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency
. Haemophilia
. 2015
;21
(1
):95
-101
.15.
Brand-Staufer
B
, Carcao
M
, Kerlin
BA
, et al. Pharmacokinetic characterization of recombinant factor XIII (FXIII)-A2 across age groups in patients with FXIII A-subunit congenital deficiency
. Haemophilia
. 2015
;21
(3
):380
-385
.16.
Miloszewski
K
, Losowsky
MS
. The half-life of factor XIII in vivo
. Br J Haematol
. 1970
;19
(6
):685
-690
.17.
Saito
M
, Asakura
H
, Yoshida
T
, et al. A familial factor XIII subunit B deficiency
. Br J Haematol
. 1990
;74
(3
):290
-294
.18.
Strilchuk
AW
, Meixner
SC
, Leung
J
, et al. Sustained depletion of FXIII-A by inducing acquired FXIII-B deficiency
. Blood
. 2020
;136
(25
):2946
-2954
.19.
Hashiguchi
T
, Saito
M
, Morishita
E
, Matsuda
T
, Ichinose
A
. Two genetic defects in a patient with complete deficiency of the B-subunit for coagulation factor XIII
. Blood
. 1993
;82
(1
):145
-150
.20.
Souri
M
, Koseki-Kuno
S
, Takeda
N
, Degen
JL
, Ichinose
A
. Administration of factor XIII B subunit increased plasma factor XIII A subunit levels in factor XIII B subunit knock-out mice
. Int J Hematol
. 2008
;87
(1
):60
-68
.21.
Byrnes
JR
, Wilson
C
, Boutelle
AM
, et al. The interaction between fibrinogen and zymogen FXIII-A2B2 is mediated by fibrinogen residues γ390-396 and the FXIII-B subunits
. Blood
. 2016
;128
(15
):1969
-1978
.22.
Ponce
RA
, Visich
JE
, Heffernan
JK
, et al. Preclinical safety and pharmacokinetics of recombinant human factor XIII
. Toxicol Pathol
. 2005
;33
(4
):495
-506
.23.
Ferrell
JE
. Feedback loops and reciprocal regulation: recurring motifs in the systems biology of the cell cycle
. Curr Opin Cell Biol
. 2013
;25
(6
):676
-686
.24.
Matsumoto
Y
, La Rose
J
, Kent
OA
, et al. Reciprocal stabilization of ABL and TAZ regulates osteoblastogenesis through transcription factor RUNX2
. J Clin Invest
. 2016
;126
(12
):4482
-4496
.25.
Shi
F-D
, Van Kaer
L
. Reciprocal regulation between natural killer cells and autoreactive T cells
. Nat Rev Immunol
. 2006
;6
(10
):751
-760
.26.
Kerlin
B
, Brand
B
, Inbal
A
, et al. Pharmacokinetics of recombinant factor XIII at steady state in patients with congenital factor XIII A-subunit deficiency
. J Thromb Haemost
. 2014
;12
(12
):2038
-2043
.27.
Machlus
KR
, Wu
SK
, Stumpo
DJ
, et al. Synthesis and dephosphorylation of MARCKS in the late stages of megakaryocyte maturation drive proplatelet formation
. Blood
. 2016
;127
(11
):1468
-1480
.28.
Sharma
A
, Jusko
WJ
. Characteristics of indirect pharmacodynamic models and applications to clinical drug responses
. Br J Clin Pharmacol
. 1998
;45
(3
):229
-239
.29.
Kattula
S
, Byrnes
JR
, Martin
SM
, et al. Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice
. Blood Adv
. 2018
;2
(1
):25
-35
.30.
Andersson
C
, Kvist
PH
, McElhinney
K
, et al. Factor XIII transglutaminase supports the resolution of mucosal damage in experimental colitis
. PLoS One
. 2015
;10
(6
):e0128113
.31.
Lauer
P
, Metzner
HJ
, Zettlmeissl
G
, et al. Targeted inactivation of the mouse locus encoding coagulation factor XIII-A: hemostatic abnormalities in mutant mice and characterization of the coagulation deficit
. Thromb Haemost
. 2002
;88
(6
):967
-974
.32.
Uhlén
M
, Fagerberg
L
, Hallström
BM
, et al. Tissue-based map of the human proteome
. Science
. 2015
;347
(6220
):1260419
.33.
Bridey
F
, Négrier
C
, Duval
C
, Ariëns
R
, de Moerloose
P
, Casini
A
. Impaired factor XIII activation in patients with congenital afibrinogenemia
. Haematologica
. 2019
;104
(3
):e111
-e113
.34.
Aleman
MM
, Byrnes
JR
, Wang
J-G
, et al. Factor XIII activity mediates red blood cell retention in venous thrombi
. J Clin Invest
. 2014
;124
(8
):3590
-3600
.35.
Suh
TT
, Holmbäck
K
, Jensen
NJ
, et al. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice
. Genes Dev
. 1995
;9
(16
):2020
-2033
.36.
Siebenlist
KR
, Meh
DA
, Mosesson
MW
. Plasma factor XIII binds specifically to fibrinogen molecules containing gamma chains
. Biochemistry
. 1996
;35
(32
):10448
-10453
.37.
Dodds
MG
, Visich
JE
, Vicini
P
. Population pharmacokinetics of recombinant factor XIII in cynomolgus monkeys
. AAPS J
. 2005
;7
(3
):E693
-E703
.38.
Souri
M
, Kaetsu
H
, Ichinose
A
. Sushi domains in the B subunit of factor XIII responsible for oligomer assembly
. Biochemistry
. 2008
;47
(33
):8656
-8664
.39.
Protopopova
AD
, Ramirez
A
, Klinov
DV
, Litvinov
RI
, Weisel
JW
. Factor XIII topology: organization of B subunits and changes with activation studied with single-molecule atomic force microscopy
. J Thromb Haemost
. 2019
;17
(5
):737
-748
.40.
Thomas
A
, Biswas
A
, Ivaskevicius
V
, Oldenburg
J
. Structural and functional influences of coagulation factor XIII subunit B heterozygous missense mutants
. Mol Genet Genomic Med
. 2015
;3
(4
):258
-271
.41.
Javed
H
, Singh
S
, Ramaraje Urs
SU
, Yadegari
H
, Oldenburg
J
. Investigating the dominant negative effect of heterozygous F13B gene mutations detected from mild FXIII deficiency patients [abstract]
. Res Pract Thromb Haemost
. 2023
;7
(Suppl 2
):100472
.42.
Schroeder
V
, Kohler
HP
. Factor XIII: structure and function
. Semin Thromb Hemost
. 2016
;42
(4
):422
-428
.43.
Gupta
S
, Biswas
A
, Akhter
MS
, et al. Revisiting the mechanism of coagulation factor XIII activation and regulation from a structure/functional perspective
. Sci Rep
. 2016
;6
(1
):30105
.44.
Ichinose
A
, Tsukamoto
H
, Izumi
T
, et al. Arg260-Cys mutation in severe factor XIII deficiency: conformational change of the A subunit is predicted by molecular modelling and mechanics
. Br J Haematol
. 1998
;101
(2
):264
-272
.45.
Maeda
S
, Zhang
WG
, Souri
M
, Yee
VC
, Ichinose
A
. Impaired dimer assembly and decreased stability of naturally recurring R260C mutant A subunit for coagulation factor XIII
. J Biochem
. 2012
;152
(5
):471
-478
.46.
Souri
M
, Ichinose
A
. Impaired protein folding, dimer formation, and heterotetramer assembly cause intra- and extracellular instability of a Y283C mutant of the A subunit for coagulation factor XIII
. Biochemistry
. 2001
;40
(45
):13413
-13420
.47.
Li
B
, Kohler
HP
, Schroeder
V
. Identification of amino acid residues that are crucial for FXIII-A intersubunit interactions and stability
. Blood
. 2020
;135
(2
):145
-152
.48.
Singh
S
, Nazabal
A
, Kaniyappan
S
, et al. The plasma factor XIII heterotetrameric complex structure: unexpected unequal pairing within a symmetric complex
. Biomolecules
. 2019
;9
(12
):765
.49.
Kamath
S
, Lip
GYH
. Fibrinogen: biochemistry, epidemiology and determinants
. QJM
. 2003
;96
(10
):711
-729
.50.
Le Quellec
S
, Enjolras
N
, Perot
E
, Girard
J
, Negrier
C
, Dargaud
Y
. Fusion of factor IX to factor XIII-B subunit improves the pharmacokinetic profile of factor IX
. Thromb Haemost
. 2018
;118
(12
):2053
-2063
.51.
Singh
S
, Akhter
MS
, Dodt
J
, et al. Identification of potential novel interacting partners for coagulation factor XIII B (FXIII-B) subunit, a protein associated with a rare bleeding disorder
. Int J Mol Sci
. 2019
;20
(11
):2682
.52.
Hurják
B
, Kovács
Z
, Döncző
B
, et al. N-glycosylation of blood coagulation factor XIII subunit B and its functional consequence
. J Thromb Haemost
. 2020
;18
(6
):1302
-1309
.53.
Suh
JH
, Miner
JH
. The glomerular basement membrane as a barrier to albumin
. Nat Rev Nephrol
. 2013
;9
(8
):470
-477
.54.
Oliver
JD
, Anderson
S
, Troy
JL
, Brenner
BM
, Deen
WH
. Determination of glomerular size-selectivity in the normal rat with Ficoll
. J Am Soc Nephrol
. 1992
;3
(2
):214
-228
.55.
Fakhouri
F
, de Jorge
E
, Brune
F
, Azam
P
, Cook
HT
, Pickering
MC
. Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice
. Kidney Int
. 2010
;78
(3
):279
-286
.56.
Jamil
MA
, Singh
S
, El-Maarri
O
, Oldenburg
J
, Biswas
A
. Exploring diverse coagulation factor XIII subunit expression datasets: a bioinformatic analysis
. Int J Mol Sci
. 2022
;23
(9
):4725
.57.
Alshehri
FSM
, Whyte
CS
, Mutch
NJ
. Factor XIII-A: an indispensable “factor” in haemostasis and wound healing
. Int J Mol Sci
. 2021
;22
(6
):3055
.58.
Swatek
KN
, Komander
D
. Ubiquitin modifications
. Cell Res
. 2016
;26
(4
):399
-422
.59.
Weiss
HJ
, Sussman
II
, Hoyer
LW
. Stabilization of factor VIII in plasma by the von Willebrand Factor: studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand’s Disease
. J Clin Invest
. 1977
;60
(2
):390
-404
.60.
Do
H
, Healey
JF
, Waller
EK
, Lollar
P
. Expression of factor VIII by murine liver sinusoidal endothelial cells
. J Biol Chem
. 1999
;274
(28
):19587
-19592
.61.
Hollestelle
MJ
, Thinnes
T
, Crain
K
, et al. Tissue distribution of factor VIII gene expression in vivo--a closer look
. Thromb Haemost
. 2001
;86
(3
):855
-861
.62.
Biswas
A
, Singh
S
, Ivaskevicius
V
, Philippou
H
, Oldenburg
J
. Structural and phylogenetic analysis of coagulation Factor XIII explains its uniqueness in the Transglutaminase family [abstract]
. Res Pract Thromb Haemost
. 2017
;1
(Suppl 1
):643
-644
.63.
Hur
WS
, Mazinani
N
, Lu
XJD
, et al. Coagulation factor XIIIa cross-links amyloid β into dimers and oligomers and to blood proteins
. J Biol Chem
. 2019
;294
(2
):390
-396
.64.
Bereczky
Z
, Balogh
E
, Katona
E
, et al. Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the high risk Hungarian population
. Thromb Res
. 2007
;120
(4
):567
-573
.65.
Raghu
H
, Cruz
C
, Rewerts
CL
, et al. Transglutaminase factor XIII promotes arthritis through mechanisms linked to inflammation and bone erosion
. Blood
. 2015
;125
(3
):427
-437
.66.
Palumbo
JS
, Barney
KA
, Blevins
EA
, et al. Factor XIII transglutaminase supports hematogenous tumor cell metastasis through a mechanism dependent on natural killer cell function
. J Thromb Haemost
. 2008
;6
(5
):812
-819
.67.
Porrello
A
, Leslie
PL
, Harrison
EB
, et al. Factor XIIIA-expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking
. Nat Commun
. 2018
;9
(1
):1988
.© 2024 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
2024
You do not currently have access to this content.
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal